Cargando…
Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
Drug-tolerant persister (DTP) cells have attracted significant interest, given their predominant role in treatment failure. In this respect, DTP cells reportedly survive after anticancer drug exposure, and their DNA repair mechanisms are altered to enhance adaptive mutation, accounting for the emerg...
Autores principales: | Zhang, Zhe, Tan, Yunhan, Huang, Canhua, Wei, Xiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982619/ https://www.ncbi.nlm.nih.gov/pubmed/36827719 http://dx.doi.org/10.1016/j.ebiom.2023.104483 |
Ejemplares similares
-
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
por: Zhang, Zhe, et al.
Publicado: (2022) -
Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure
por: Fu, Liwu, et al.
Publicado: (2022) -
Repurposing antifungal drugs for cancer therapy
por: Weng, Ningna, et al.
Publicado: (2022) -
Redox signaling at the crossroads of human health and disease
por: Zuo, Jing, et al.
Publicado: (2022) -
Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress
por: Zhang, Zhe, et al.
Publicado: (2018)